TrialAnnals of the rheumatic diseases2003

Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.

J A Stakkestad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.